Neurocrine Biosciences
Research & Development and Corporate Offices

DBC was awarded the project based on our reputation as a leader in the biotech construction industry, our proven ability to meet project schedules within an established budget and the ability to develop a competitive fee structure. DBC was successful in value engineering the budget from an early amount of $14 million to a final contract amount of $11.75 million. DBC was also able to cut the schedule by three weeks in spite of a record high 'El Nino' rain season. The project was completed ahead of schedule and within budget.